Comprehensive Guide to Addiction Medications and T

This detailed chart outlines key addiction medications, their indications, neurotransmitter targets, side effects, dosing, and special considerations for age, pregnancy, and breastfeeding in the treatment of opioid and alcohol dependence.

Mason Bennett
Contributor
4.6
42
4 months ago
Preview (2 of 5 Pages)
100%
Purchase to unlock

Page 1

Comprehensive Guide to Addiction Medications and T - Page 1 preview image

Loading page image...

Addiction Medications TableWeek BCH O WBl. M NH M V n t M T V“HIS ASSIGNMENT SHOULD BE SUBMITTED TO THE WEEK 5 MEDICATION TABLE DROPBOX BY SUNDAY AT 11 59 P.M. MT.Drug NameIndicationNeurotransmitterfs)AffectedTarget SymptomsHalf-life (Tl'2),Metabolism (CYP 450enzyme)Notable Side Effects(link to NT or affectedbrain circuit)Initial DosingConsiderationsSpecific lifespanconsiderations(age, pregnancy,breastfeeding)Buprenorphine(Subutex)Indication:Maintenancetreatment of opioiddependenceMaintenancetreatment of opioiddependence inpatients who haveachieved andsustained prolongedclinical stability onlow-to moderatedoses of a transmucosalbuprenorphinecontaining productModerate to severeopioid use disorder inpatients who haveinitiated treatmentwith a transmucosal24-42hoursCYP450:CYP3A424-42hoursCYP450:CYP3A4Half-life: 24-42 hoursCYP450: CYP3A4Headache,constipation, nauseaOral hypoesthesia,glosscdyniaOrthostatichypotensionRespiratory distressHepatotoxicityBinds to mu opioidreceptorsInitial dosing:Sublingual 8-32mg dayControlled studieshave not beenconducted inpregnant women.Buprenorphinemay be preferableto methadone inpregnant women.Neonatal opioidwithdrawalsyndrome has beenreported followinguse ofBuprenorphineduring pregnancySome drag isbuprenorphinecontaining product,followed by doseadjustment for aminimum of 7 daysNeurotransmitteraffected: Mu opioidreceptor partialagonist Antagonist atthe kappa opioidreceptorTarget symptoms:Opioid dependencefound in mother'sbreast milk.Recommendedeither todiscontinued drugor formula feed.Use with cautionin elderly. Somepatients maytolerate lowerdoses better.Buprenorphine Naloxone(Suboxone, Zubsolv,Bunavail)Indication:Treatment, andmaintenance ofopioid dependence.Induction oftreatment for opioiddependenceMaintenancetreatment of opioiddependence inpatients who haveachieved andsustained prolongedclinical stability onlow-to moderateSuboxone: 24-42 hoursNaloxone: 2-12 hoursCYP450: CYP3A4Headache,constipation, nausea,oral hypcesthesia,glosscdynia,orthostatichypotension, sedationBinding at mu opioidreceptorsInitial dosing:Bunavail: Day 1:induction dose:Initial: Buccal:Buprenorphine 2.1mg naloxone 0.3mg; may repeatdose after 2 hours,based on control ofacute withdrawalsymptoms;maximum totaldose:buprenorphine 4.2mg naloxone 0.7mg. Day 2:

Page 2

Comprehensive Guide to Addiction Medications and T - Page 2 preview image

Loading page image...

doses of a transmucosalNeurotransmitters:Antagonist at thekappa opioid receptorMu opioid receptorpartial agonistTarget symptoms:Opioid dependenceinduction dose: Upto buprenorphine8.4 mg naloxone1.4 mg as a singledose Suboxone:Day 1: inductiondose: Initial:Sublingual:Buprenorphine 2mg naloxone 0.5mg orbuprenorphine 4mg naloxone 1mg; may titratedose, based oncontrol of acutewithdrawalsymptoms, inbuprenorphine 2mg naloxone 0.5mg orbuprenorphine 4mg naloxone 1 mgincrementsapproximatelyevery 2 hours up toa total dose ofbuprenorphine 8mg naloxone 2mg. Day 2:induction dose:Sublingual: Up tobuprenorphine 16mg naloxone 4 mgas a single dose.Zubsolv: Day 1:induction dose:Sublingual: Stanwith an initial doseof buprenorphine1.4 mg naloxoneC.36 mg; based oncontrol of acutewithdrawalsymptoms, mayadministeradditional doses inincrements of 1 to2 buprenorphine1.4 mg naloxoneC.36 mg tabletsevery 1.5 to 2hours to a total day1 dose up tobuprenorphine 5.7mg naloxone 1.4mg. Some patients(eg, those withrecent exposure tobuprenorphine)may tolerate up tobuprenorphine 4.2mg naloxone 1.08mg as a single,
Preview Mode

This document has 5 pages. Sign in to access the full document!

Study Now!

XY-Copilot AI
Unlimited Access
Secure Payment
Instant Access
24/7 Support
Document Chat

Document Details

Related Documents

View all